Condition: Kidney Stone · Sponsor: Insel Gruppe AG, University Hospital Bern
The aim of this study is to test the efficacy of the two long-acting thiazide-like diuretics indapamide and chlorthalidone in reducing urine supersaturation for calcium oxalate and calcium phosphate compared to the short-acting thiazide diuretic hydrochlorothiazide for the prevention of calcium-containing kidney stones.
This description comes directly from the study's public registry record.
Daniel G Fuster, M.D. · +41 (0)31 632 31 44 · daniel.fuster@insel.ch
Always discuss trial participation with your own doctor first.
| Inselspital, Department of Nephrology and Hypertension | Bern, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06111885